| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -58.4% |
| R&D Expense | $125.4M | -43.7% |
| SG&A Expense | $70.0M | -45.3% |
| Operating Income | -$192.8M | +44.1% |
| Interest Expense | $10.2M | +80.8% |
| Pre-tax Income | -$198.3M | +43.0% |
| Income Tax | $0 | — |
| Net Income | -$198.3M | +43.0% |
| EPS (Basic) | -$1.46 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.3M | -65.8% |
| Short-term Investments | $59.4M | +274.0% |
| Accounts Receivable | $1.4M | +0.0% |
| Current Assets | $168.3M | -49.2% |
| Total Assets | $193.6M | -49.0% |
| Current Liabilities | $53.2M | -18.6% |
| Long-term Debt | $71.1M | +5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$176.2M | +40.4% |
| Capital Expenditures | $14K | -96.5% |
| Investing Cash Flow | -$20.0M | -5928.0% |
| Financing Cash Flow | -$391K | -100.9% |
| Free Cash Flow | -$176.2M | +40.5% |
| +44.5% |
| EPS (Diluted) | -$1.46 | +44.5% |
| Total Liabilities |
| $135.0M |
| -5.3% |
| Stockholders' Equity | $58.6M | -75.3% |